Skip to main content
. Author manuscript; available in PMC: 2021 Aug 31.
Published in final edited form as: Biol Blood Marrow Transplant. 2020 Mar 19;26(7):1342–1349. doi: 10.1016/j.bbmt.2020.03.011

Table 5.

AEs by Diagnostic Criteria

VOD/SOS Diagnosed by:
n (%) All VOD/SOS Criteria (N = 803) Baltimore Criteria (n = 449) Modified Seattle Criteria (n = 331) Biopsy (n = 23)
Treatment-emergent AEs 565 (70) 333 (74) 215 (65) 17 (74)
Most common (>5% in all patients)
 Multiorgan failure 87 (11) 62 (14) 23 (7) 2 (9)
 Hypotension 86 (11) 55 (12) 28 (8) 3 (13)
 Respiratory failure 67 (8) 38 (8) 27 (8) 2 (9)
 Diarrhea 55 (7) 29 (6) 23 (7) 3 (13)
 Veno-occlusive liver disease* 53 (7) 40 (9) 8 (2) 5 (22)
 Pulmonary hemorrhage 51 (6) 34 (8) 17 (5) 0
 Pyrexia 49 (6) 29 (6) 19 (6) 1 (4)
 Vomiting 44 (5) 16 (4) 23 (7) 5 (22)
 Renal failure 41 (5) 25 (6) 15 (5) 1 (4)
Serious AEs 421 (52) 273 (61) 135 (41) 13 (57)
Treatment-related AEs 167 (21) 90 (20) 74 (22) 3 (13)
 Leading to discontinuation 100 (12) 58 (13) 41 (12) 1 (4)
 Leading to death 23 (3) 16 (4) 7 (2) 0
Hemorrhage 229 (29) 139 (31) 83 (25) 7 (30)
Hypotension 87 (11) 56 (12) 28 (8) 3 (13)
*

AEs were reported by investigators; by definition, all patients had veno-occlusive liver disease.